Cargando…
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
Autores principales: | Tomuleasa, Ciprian, Cucuianu, Andrei, Aldea, Mihaela, Berindan-Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810497/ https://www.ncbi.nlm.nih.gov/pubmed/24187496 http://dx.doi.org/10.2147/IJN.S53962 |
Ejemplares similares
-
Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima, Seiji, et al.
Publicado: (2014) -
MRI-based identification of undifferentiated cells: looking at the two faces of Janus
por: Tomuleasa, Ciprian, et al.
Publicado: (2014) -
Long Non-coding RNAs in Myeloid Malignancies
por: Zimta, Alina-Andreea, et al.
Publicado: (2019) -
Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
por: Simon, Timea, et al.
Publicado: (2015) -
Nanopharmacology in translational hematology and oncology
por: Tomuleasa, Ciprian, et al.
Publicado: (2014)